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RESUMO
Introdução: O Endometriosis Health Profile Questionnaire-30 é atualmente o questionário mais utilizado para avaliação da qualidade 
de vida em mulheres com endometriose. O objetivo do presente estudo é avaliar as propriedades psicométricas e validar a versão 
portuguesa do Endometriosis Health Profile Questionnaire-30.
Material e Métodos: Amostra sequencial de conveniência, constituída por 152 doentes com endometriose, de um centro de 
referência no país, que autopreencheram um questionário sociodemográfico, a versão portuguesa do Endometriosis Health Profile 
Questionnaire-30 e do Short Form Health Survey 36 Item–versão 2. Procedeu-se a análise estatística apropriada, com estatística 
descritiva, análise fatorial, avaliação da consistência interna, correlação item-total e validade convergente (usando o Short Form 
Health Survey 36 Item–versão 2).
Resultados: A análise fatorial confirmou a validade da estrutura em cinco dimensões do questionário central, explicando uma variância 
total de 83,2%. A correlação item-total apresentou resultados aceitáveis em todos os itens e a consistência interna foi elevada, com  α 
Cronbach variando de 0,876 a 0,981 nas dimensões do questionário central, e de 0,863 a 0,951 no modular. Demonstrou-se associação 
negativa significativa entre as dimensões similares do Endometriosis Health Profile Questionnaire-30 e do Short Form Health Survey 
36 Item–versão 2. A taxa de preenchimento do questionário foi elevada para todas as dimensões. A perda do bem-estar emocional (no 
questionário central) e a infertilidade (no modular) apresentaram as pontuações médias mais elevadas e, consequentemente, impacto 
mais negativo sobre a qualidade de vida.
Discussão: São necessários estudos para avaliar a fiabilidade teste-reteste e a sensibilidade à mudança desta versão portuguesa do 
Endometriosis Health Profile Questionnaire-30.
Conclusão: Este estudo demonstra que a versão portuguesa do Endometriosis Health Profile Questionnaire-30 é um instrumento 
adaptado, validado e bem aceite para a avaliação da qualidade de vida das mulheres portuguesas com endometriose.
Palavras-chave: Endometriose; Qualidade de Vida; Questionários; Portugal.
ABSTRACT
Introduction: Endometriosis Health Profile Questionnaire-30 is currently the most used questionnaire for quality of life measurement in 
women with endometriosis. The aim of this study is to evaluate the psychometric properties and to validate the Portuguese Endometriosis 
Health Profile Questionnaire-30 version.
Material and Methods: A sequential sample of 152 patients with endometriosis, followed in a Portugal reference center, were 
asked to complete a questionnaire on social and demographic features, the Portuguese version of the Endometriosis Health Profile 
Questionnaire-30 and of the Short Form Health Survey 36 Item – version 2. Appropriate statistical analysis was performed using 
descriptive statistics, factor analysis, internal consistency, item-total correlation and convergent validity.
Results: Factorial analysis confirmed the validity of the five-dimension structure of the Endometriosis Health Profile Questionnaire-30 
core questionnaire, which explained 83.2% of the total variance. All item-total correlations presented acceptable results and high internal 
consistency, with Cronbach’s alpha ranging between 0.876 and 0.981 for the core questionnaire and between 0.863 and 0.951 for the 
modular questionnaire. Significant negative associations between similar scales of Endometriosis Health Profile Questionnaire-30 
and Short Form Health Survey 36 Item – version 2 were demonstrated. Data completeness achieved was high for all dimensions. The 
emotional well-being scale in the core questionnaire and the infertility scale in the modular section had the highest median scores, and 
therefore the most negative impact on the quality of life of participating women.
Discussion: The test-retest reliability and responsiveness of the questionnaire should be evaluated in future studies.
Conclusion: The present study demonstrates that the Portuguese version of the Endometriosis Health Profile Questionnaire-30 is a 
valid, reliable and acceptable tool for evaluating the health-related quality of life of Portuguese women with endometriosis.
Keywords: Endometriosis; Quality of Life; Questionnaires; Portugal.
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INTRODUCTION
 Endometriosis is a chronic, frequently progressive and 
relapsing disease, characterised by the presence of extra-
uterine glandular tissue and endometrial stroma. Although 
difficult to estimate, it is thought that approximately 10% 
of reproductive-age women are affected, corresponding to 
176 million women with endometriosis worldwide.1 Endo-
metriosis may present with dysmenorrhea, chronic pelvic 
pain, dyspareunia, dysuria, dyschezia, infertility and abnor-
mal uterine bleeding and may induce important physical, 
emotional and social morbidity affecting quality of life.2-5
 Health-related quality of life is a multidimensional and 
dynamic concept, involving physical, psychological and 
social issues related to a disease or its treatment.3,6 As 
endometriosis globally affects women’s life, the assessment 
of treatment’s efficacy based on pain improvement and 
fertility rates alone is clearly insufficient.7,8 In addition, the 
lack of correlation between symptom intensity and the 
severity and extension of lesions is largely recognized9 and 
the patient’s subjective assessment of her own quality of life 
is crucial for an optimal approach to endometriosis.
 Several studies have recently shown a decreased quality 
of life in patients with endometriosis.10,11 However, only 
generic instruments (namely the Nottingham Health Profile, 
Short Form-36 and Short Form-12) lacking sensitivity for the 
detection of changes and response to therapy in specific 
and complex diseases such as endometriosis have been 
used.4,12-15 An endometriosis-specific instrument sensitive to 
changes in patient’s health and quality of life is therefore 
required.2
 The Endometriosis Health Profile Questionnaire-30 
(EHP-30) is currently the most used and validated 
instrument for the assessment of quality of life in patients 
with endometriosis16,17 and is recommended by the 
American Society for Reproductive Medicine (ASRM), as 
well as by the European Society of Human Reproduction 
and Embryology.18 In fact, it was already shown that the 
EHP-30 is sensitive to changes in health status over time in 
patients with endometriosis.19,20 
 EHP-30 was developed in 2001 in the UK, involving 
exploratory interviews in patients with surgically confirmed 
endometriosis.2 This is a self-reported questionnaire with a 
30-item, five-dimension (pain, control and powerlessness, 
emotional well-being, social support and self-image) core 
part and an optional 23-item modular questionnaire divided 
into 6 dimensions (that may not apply to every woman 
as regards work, relationship with child/children, sexual 
relationship, feelings about medical profession, feelings 
about treatment and feelings about infertility).2,21 Each scale 
is translated into a scoring system ranging from 0-100 and 
the lower the score, the better the patient’s quality of life. 
The EHP-30 is already validated for North America context 
and includes Australian, Dutch, Italian, Chinese, Iranian 
and Brazilian Portuguese versions.8,16,17,21-24 The translation 
process to a culture-adapted Portuguese version of the 
EHP-30 has been recently carried out.25,26 However, this 
instrument has so far not been validated, which would allow 
for the assessment of quality of life in Portuguese patients, 
as well as for the comparison with different international 
studies using the same instrument. 
 Our study aimed to assess the psychometric properties 
and the validation of the Portuguese version of the EHP-30 
used in Portuguese women diagnosed with endometriosis 
in a reference hospital.
MATERIAL AND METHODS
Questionnaire adaptation
 Translation (semantic and content equivalence obtained 
from two independent translations and two retroversions; 
consensus and reviewed version obtained from physicians) 
and content validation (from a panel of 20 patients with 
endometriosis) were previously obtained.25,26 This translated 
and culture-adapted version was used in the present study, 
upon authorization from the authors.
Psychometric studies and validation
 The study was approved by the Ethics Committee 
of the Centro Hospitalar Lisboa Norte (CHLN) - Hospital 
Universitário de Santa Maria. 
 All patients included in the study participated voluntarily 
and were informed about its aims, its anonymity and 
confidentiality, as well as about the possibility of suspending 
or interrupting the participation at any point without any kind 
of penalty or loss for that reason, namely regarding her right 
to medical assistance. All participants signed an informed 
consent before questionnaire completion.
Sample and questionnaires
 Our study involved a convenience sequential sample 
of 152 reproductive-age women above 18 years of age 
diagnosed with endometriosis, followed at the Gynaecology 
Department from the Clínica Universitária de Obstetrícia 
e Ginecologia do CHLN/ Hospital Universitário de Santa 
Maria. This is a reference outpatient department for patients 
with endometriosis and therefore attends to patients from 
across the country (although with a predominance for the 
region of Lisbon and Tagus Valley).
 The size of the sample was determined according to the 
recommendations by Hair et al.:27 at least 100 participants 
and five times more observations than the number of items 
to be analysed. The presence of another physical or mental 
disease with any relevant impact on quality of life was 
considered as an exclusion criteria. 
 The following questionnaires were applied to all the 
patients: socio-demographic questionnaire (patient’s age, 
nationality, ethnicity, schooling, occupation and marital 
status), Portuguese version of the EHP-30 and Portuguese 
version of the Short Form Health Survey 36 Item – 
version 2 (SF-36v2). This 36-item questionnaire has been 
validated for the Portuguese population and includes eight 
dimensions (physical functioning, role physical, bodily pain, 
general health, vitality, social functioning, role emotional 
and mental health), allowing for assessment of aspects 
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regarding physical and mental health. Each dimension was 
scored on a 0 to 100 scale and the higher the score, the 
better the quality of life.28
 Questionnaires were self-reported by patients 
undergoing treatment for endometriosis (watchful waiting, 
medical or surgical), waiting for their medical appointment 
in the Outpatient Department, between the 8th April 2013 
and the 31st March 2014.
 Data were also obtained through a clinical form 
completed by the physician in charge of the patient, including 
the symptoms described during the four weeks prior to 
the medical appointment and the stage of endometriosis 
(according to the ASRM classification).29
Statistical analysis
 Six criteria were used for the assessment of psychometric 
properties of the questionnaire, namely exploratory 
factorial analysis, internal consistency evaluation, item-
total correlation, convergent validity, data completeness 
and score distribution. The Statistical Package for Social 
Sciences (SPSS®, version 22.0) was used for the analysis. 
A descriptive analysis was previously performed, using 
frequency distribution, central tendency and dispersion 
measurements for the variables in the study. The results 
regarding quantitative variables are presented as mean ± 
standard deviation. In order to determine the factor structure 
of the questionnaire, the exploratory factor and principal 
component analysis (with Varimax rotation) of the core part 
of the EHP-30 was obtained. In order to assess the internal 
consistency for each scale of the core and modular parts 
the Cronbach’s alpha coefficient was used and values ≥ 
0.7 were considered as acceptable.27 Values of item-total 
correlation above 0.4 were considered as acceptable.27 In 
order to determine the convergent validity, in line with the 
study describing the design of the original version as well 
as the versions in other languages, a significant correlation 
between the dimensions of the EHP-30 and the SF-
36v2 was hypothesized.2,5,23 The convergent validity was 
determined by Pearson’s coefficient. Statistical significance 
was established for values of p < 0.05. 
RESULTS
 A 34.7 ± 6.1 years (range: 19-49) average age was found 
in the 152 patients with endometriosis in our study, mostly 
Portuguese (96.1%), Caucasian (88.2%) and married or 
living as a couple (69.6%). As regards schooling, 40.8% (n = 
62) completed high-school education, while 38.2% (n = 58) 
had a college degree; 78.9% (n = 120) of the participants 
were professionally active (Table 1).
 As regards clinical data, 66.4% (n = 101) of our 
patients presented with stage IV endometriosis according 
to the ASMR classification and most patients described 
dysmenorrhoea (63.6%), dyspareunia (54.8%), chronic 
pelvic pain (50.0%), asthenia (59.2%) and gastrointestinal 
symptoms (54.6%) over the four weeks prior to  questionnaire 
completion (Table 1).
Exploratory factor analysis
 The factor analysis of the core questionnaire was 
performed defining a maximum of five factors, in order 
to determine whether the current structure reflected the 
structure in the original version of the EHP-30. The original 
study describing the design of the EHP-30 assumed there 
was no correlation between the factors and therefore used 
a Varimax rotation,2 which was therefore also used in our 
study. Those items with a minimum 0.4 factor saturation in 
the principal component analysis were maintained for the 
factor analysis (i.e. all the items were maintained) (Table 2). 
 The five-factor analysis (all with values above 1) 
explained for 83.2% of variance and the percentage of 
variance explained by each factor was 36.8% for pain, 
18.6% for control and powerlessness, 12.2% for emotional 
well-being, 8.2% for social support and 7.4% for self-image. 
All the items were more clearly saturated in the correct 
dimension, except six (Table 2): the item ‘Em geral, sentiu-
se mal’ (‘Generally felt unwell’) was associated to the ‘pain’ 
dimension; the items ‘Sintomas não estão a melhorar’, 
‘Incapacidade de controlar sintomas’, ‘Sintomas a controlar 
a vida’ and ‘Sintomas a tirar a vida’ (‘Felt frustrated because 
your symptoms are not getting better’, ‘Felt frustrated 
because you are not able to control your symptoms’, ‘Felt 
as though your symptoms are ruling your life’ and ‘Felt your 
symptoms are taking away your life’) were associated to 
the dimension ‘pain’ beyond the dimension hypothesized 
(‘control and powerlessness’); finally, the item ‘Incapacidade 
de dizer como se sente’ (‘Felt unable to tell people how you 
feel’) was associated to the hypothesized dimension (‘social 
support’), beyond the dimension ‘emotional well-being’.
 Upon establishing the five first-order dimensions, 
these were submitted to a new factor analysis, in order 
to determine whether a single second-order component 
emerged. The results showed that it is possible to generate 
a single component explaining for 78.0% of variance. This 
means that the dimensions may be added in order to obtain 
a single score. A high principal component factor saturation 
for the five dimensions was found (pain: 0.877; control and 
powerlessness: 0.906; emotional well-being: 0.903; social 
support: 0.897; self-image: 0.831).
Item-total correlation and internal consistency 
assessment
 An item-total correlation above 0.4 was found in all 
the items in the short-form core (variation: 0.656 – 0.951; 
Table 3) and modular questionnaires (variation: 0.573 – 
0.937; Table 4) of the EHP-30, showing a good item-total 
consistency. 
 A Cronbach’s alpha above 0.7 was found for all the 
dimensions in internal consistency assessment, varying 
between 0.876 and 0.981 in the dimensions in the core 
questionnaire (Table 3) and between 0.863 and 0.951 in the 
dimensions in the modular questionnaire (Table 4).
Convergent validity
 When applying the Pearson’s correlation between 
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the dimensions in the EHP-30 and SF-36v2, a significant 
correlation for all assessed dimensions was found, which 
was maximum between the dimension ‘pain’ from the EHP-
30 and the dimension ‘bodily pain’ from the SF-36v2 (r = 
-0.739); (Table 5).
Data completeness, descriptive statistics and 
sensitivity of the different dimensions 
 The average time for completion of the EHP-30 was 
13.84 ± 6.1 minutes (minimum three minutes; maximum 30 
minutes). 
 High data completeness (96.7% in the dimension ‘pain’ 
and 100% in ´social support’ and self-image’) by the 152 
patients in our group of participants was found. As regards 
the modular questionnaire, the n likely to respond to 
each dimension depends on personal circumstances, as 
not all the dimensions apply to all patients (for instance, 
‘relationship with child/children’ does not apply to patients 
with no children). Therefore, according to the n likely to 
respond, data completeness varied between 93.1% in the 
dimension ‘relationship with child/children’ and 98.6% in the 
‘feelings about infertility’ dimension.
 The descriptive statistics and values of asymmetry 
and kurtosis for the dimensions included in the EHP-30 
are shown in Table 6. Except for ‘feelings about medical 
profession’, all the dimensions showed negative flatness 
values (platykurtic distribution) and close-to-zero asymmetry 
values. We may therefore assume that, except for ‘feelings 
about medical profession’, the dimensions do not show 
relevant sensitivity or normality issues. As regards the core 
questionnaire, the ‘emotional well-being’ dimension showed 
the highest average score (41.2) and therefore the most 
negative impact on the quality of life. In addition, the ‘self-
image’ dimension showed the lowest average score (34.1). 
In the modular questionnaire, ‘feelings about infertility’ 
showed the highest average score (55.9) and the most 
important negative impact on quality of life and ‘feelings 
about medical profession’ showed the lowest values (12.8) 
(Table 6).
DISCUSSION
 Our study involved the psychometric assessment of 
the Portuguese version of the EHP-30, that was previously 
only translated,25,26 according to the recommendations 
of the International Society for Pharmacoeconomics and 
Outcomes Research.30 This allows for the validation of the 
EHP-30 as well as its clinical application to the assessment 
of quality of life in Portuguese women with endometriosis.
 Our group of patients had an average age (34.7) in 
line with the average age of Portuguese women within 
the 18-49 age group – 34.65.31 As regards schooling, 
40.8% had completed high school and 38.2% had a 
college degree, corresponding to a high-schooling sample 
regarding Portugal average. In fact, according to Censos 
2011 (Portuguese 2011 Census data), around 15% of the 
Portuguese population aged 23 or above had completed 
a college degree, from which 60% were women.32 
Table1 - Socio-demographic and clinical characteristics of our 
group of patients (n = 152)
Socio-demographic characteristics
  Age* 34.7 ± 6.1 (19 - 49)
Nationality, n (%)
  Portuguese 146 (96.1%)
  Othera 6 (3.9%)
Ethnicity, n (%)
  Caucasian 134 (88.2%)
  Black 12 (7.9%)
  Other 6 (3.9%)
Schooling, n (%)
  1st Cycle 0 (0.0%)
  2nd Cycle 2 (1.3%)
  3rd Cycle 20 (13.2%)
  Secondary level 62 (40.8%)
  Undergraduate 10 (6.6%)
  College degree 48 (31.6%)
  Masters / PhD 10 (6.6%)
Profession, n (%)
   Active 120 (78.9%)
  Student 6 (3.9%)
   Non-workingb 26 (17.1%)
Marital status, n (%)
  Single 33 (21.7%)
  Married / Living as a couple 106 (69.6%)
  Divorced / Separated 12 (7.9 %)
  Widow 1 (0.7%)
Clinical characteristics
  Endometriosis classification, n (%)c
    Stage I 1 (0.7%)
    Stage II 13 (8.6%)
    Stage III 37 (24.3%)
    Stage IV 101 (66.4%)
  Symptoms, n (%)d
    Dysmenorrhea (n = 88) 56 (63.6%)
    Dysuria 23 (15.1%)
    Dyschezia 57 (37.5%)
    Dyspareunia (n = 115) 63 (54.8%)
    Chronic pelvic pain 76 (50.0%)
    Asthenia 90 (59.2%)
    Gastrointestinal symptoms 83 (54.6 %)
    Abnormal uterine bleeding 37 (24.3%)
    Time since the first symptoms* 9.6 ± 7.4 (1 - 31)
*mean ± standard deviation (range); age, time since the first symptoms: years; a: from 
other nationality although living in Portugal for more than 5 years; b: includes unemployed 
and housewives; c: Classification according to the American Society of Reproductive Me-
dicine; stage I – minimum, stage II – mild, stage III – moderate, stage IV – severe31; 
d: different n for dysmenorrhea and dyspareunia, as it is not applicable to all the situations.
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Table 2 - Factor analysis of the core questionnaire of the EHP-30 (principal component analysis with Varimax rotation)
Communalities Factor saturation
Pain Control and 
powerless-
ness
Emotional 
well-being
Social 
support
Self-image
1. Incapacidade de ir a acontecimentos sociais 0.844 0.808
2. Incapacidade de fazer tarefas domésticas 0.861 0.843
3. Dificuldades em estar em pé 0.874 0.868
4. Dificuldades em sentar-se 0.794 0.831
5. Dificuldades em andar 0.892 0.859
6. Dificuldades em fazer exercício ou atividades de lazer 0.883 0.854
7. Perda de apetite e/ou incapaz de comer 0.781 0.766
8. Incapacidade de dormir bem 0.842 0.816
9. Necessidade de ir para a cama/ deitar-se 0.830 0.815
10. Incapacidade de fazer as coisas que queria 0.923 0.860
11. Incapacidade de lidar com as dores 0.859 0.759
12. Em geral, sentiu-se mal 0.841 0.801
13. Sintomas não estão a melhorar 0.857 0.624 0.508
14. Incapacidade de controlar sintomas 0.874 0.649 0.496
15. Incapacidade de esquecer os sintomas 0.754 0.726
16. Sintomas a controlar a vida 0.879 0.623 0.520
17. Sintomas a tirar a vida 0.872 0.550 0.479 0.458
18. Sentir-se deprimida 0.834 0.729
19. Sentir-se com vontade de chorar 0.854 0.701
20. Sentir-se extremamente infeliz 0.770 0.661 0.404
21. Alterações de humor 0.877 0.839
22. Sentir-se mal-humorada ou irritável 0.870 0.811
23. Sentir-se violenta ou agressiva 0.658 0.635
24. Incapacidade de dizer como se sente 0.747 0.515 0.425
25. Sentir que os outros não compreendem 0.875 0.448 0.674
26. Sentir que os outros pensam que se está a lamuriar 0.889 0.693
27. Sentir-se sozinha 0.738 0.548 0.499
28. Não poder vestir as roupas que queria 0.778 0.785
29. Sentir aparência afetada 0.821 0.772
30. Falta de confiança 0.775 0,671
Cronbach’s alpha 0.878 0.908 0.902 0.901 0.839
Own values 11.05 5.57 3.65 2.45 2.22
Total variance explained by each factor 
(accumulated)
36.8% 18.6% 
(55.4%)
12.2% 
(67.6%)
8.2% 
(75.8%)
7.4% 
(83.2%)
A
R
TIG
O
 O
R
IG
IN
A
L
352Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                
However, this schooling level is below those described for 
other populations, like for instance, from Brazil. Bellelis 
et al., on a retrospective study about epidemiological and 
clinical aspects of pelvic endometriosis, involving 892 
patients, described that 51.9% of these had completed a 
college degree.33
 According to the ASMR classification, all stages 
of endometriosis are represented in our group of 
patients. However, most women presented with stage-IV 
endometriosis, explained by the fact that the questionnaire 
was applied to patients attending a reference Gynaecology 
Outpatient Department for patients with endometriosis, 
mainly with advanced disease. The lack of correlation 
between symptom intensity (and therefore worse quality of 
life) and disease severity1 shown in our study by the ASMR’s 
surgical classification is well recognized. Therefore, there 
is no evidence that the asymmetric distribution of surgical 
stages in our group of patients may have influenced the 
assessment of the quality of life.
 As regards the exploratory factor analysis aimed 
Table 3 - Internal consistency of the core questionnaire of the EHP-30 (Cronbach’s alpha)
Dimensions Item-total correlation
Pain (α = 0.981; n = 147)
  1. Incapacidade de ir a acontecimentos sociais 0.901
  2. Incapacidade de fazer tarefas domésticas 0.913
  3. Dificuldades em estar em pé 0.919
  4. Dificuldades em sentar-se 0.853
  5. Dificuldades em andar 0.923
  6. Dificuldades em fazer exercício ou atividades de lazer 0.918
  7. Perda de apetite e/ou incapaz de comer 0.848
  8. Incapacidade de dormir bem 0.898
  9. Necessidade de ir para a cama/ deitar-se 0.889
  10. Incapacidade de fazer as coisas que queria 0.951
  11. Incapacidade de lidar com as dores 0.892
Control and powerlessness (α = 0.947; n = 150)
  12. Em geral, sentiu-se mal 0.802
  13. Sintomas não estão a melhorar 0.895
  14. Incapacidade de controlar sintomas 0.912
  15. Incapacidade de esquecer os sintomas 0.656
  16. Sintomas a controlar a vida 0.913
  17. Sintomas a tirar a vida 0.851
Emotional well-being (α = 0.943; n = 151)
  18. Sentir-se deprimida 0.874
  19. Sentir-se com vontade de chorar 0.883
  20. Sentir-se extremamente infeliz 0.803
  21. Alterações de humor 0.874
  22. Sentir-se mal-humorada ou irritável 0.872
  23. Sentir-se violenta ou agressiva 0.667
Social support (α = 0.912; n = 152)
  24. Incapacidade de dizer como se sente 0.764
  25. Sentir que os outros não compreendem 0.857
  26. Sentir que os outros pensam que se está a lamuriar 0.854
  27. Sentir-se sozinha 0.735
Self image (α = 0.876; n = 152)
  28. Não poder vestir as roupas que queria 0.758
  29. Sentir aparência afetada 0.810
  30. Falta de confiança 0.717
Nogueira-Silva C, et al. Validation of the portuguese version of EHP-30, Acta Med Port 2015 May-Jun;28(3):347-356
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to determine the dimensions produced by the analysis 
made within the original questionnaire’s development, 
five dimensions were included in the core questionnaire’s 
structure. However, six items were saturated in other than 
the hypothesized factor, i.e. beyond the original dimension. 
In fact, the items in ‘control and powerlessness’, ‘generally 
feeling unwell’, ‘felt frustrated because your symptoms are 
not getting better’, ‘felt frustrated because you are not able 
to control your symptoms’, ‘felt as though your symptoms 
are ruling your life’ and ‘felt your symptoms are taking 
away your life’ items were also associated from the ‘pain’ 
dimension. Not surprisingly, this was also found in the 
secondary factor analysis carried out in 2006 for the original 
version34 as pain is a cardinal symptom in endometriosis 
and may have a negative influence on how the disease is 
perceived.1 In addition, the ‘Felt unable to tell people how 
you feel’ item was associated to ‘emotional well-being’, 
beyond the ‘social support’ dimension. This association was 
also described in the North American version21 and is easily 
explained as the ability to communicate depends on the 
emotional well-being.
 It should be mentioned that the new factor analysis 
confirmed the emergence of a single second-order 
component that explains for 78% of the variance, in line with 
the original version, as well as in the North American and 
Iranian versions.2,21,24 This means that the dimensions may 
be added in order to obtain a single score.
 A high internal consistency was found for all the 
dimensions of both the core and the modular questionnaires, 
with a Cronbach’s alpha above 0.7. In fact, eight of the 11 
dimensions (72.7%) in the EHP-30 presented values above 
0.9, showing that these dimensions would be adequate for 
patient’s individual analysis. Cronbach’s alpha values in our 
study were similar and even higher to those described in 
the original study, except for ‘relationship with child/children’ 
(0.916 vs. 0.97), ‘sexual relationship’ (0.941 vs. 0.96) and 
‘feelings about infertility’ (0.880 vs. 0.92) dimensions.2 In 
addition, these were higher to those found in the Brazilian-
Table 4 - Evaluation of internal consistency of the modular questionnaire of the EHP-30 (Cronbach’s alpha)
Dimensions Item-total correlation
Work (α = 0.951; n = 117 in 120)
  1. Ausência do trabalho 0.843
  2. Incapacidade para cumprir deveres no trabalho 0.924
  3. Embaraçada com sintomas no trabalho 0.784
  4. Sentimento de culpa por ausência do trabalho 0.891
  5. Preocupação por não ser capaz de fazer o trabalho 0.896
Relationship with child/children (α = 0.916; n = 54 in 58) 
  1. Dificuldade em cuidar dos filhos 0.846
  2. Incapacidade de brincar com os filhos 0.846
Sexual relationship (α = 0.941; n = 112 in 115)
  1. Dores na relação sexual 0.757
  2. Preocupação com a relação sexual 0.910
  3. Evitar relação sexual 0.860
  4. Sentir-se culpada por não querer ter relação sexual 0.871
  5. Angustiada por não conseguir ter prazer na relação sexual 0.813
Feelings about medical profession (α = 0.948; n = 121 in 123)
  1. Médico não está a fazer nada por si 0.937
  2. Médico acha que é tudo da sua cabeça 0.897
  3. Angustiada com a falta de conhecimentos do médico 0.872
  4. Sentir que faz perder tempo ao médico 0.812
Feelings about treatment (α = 0.863; n = 100 in 103)
  1. Angustiada porque o tratamento não está a funcionar 0.731
  2. Dificuldade em lidar com os efeitos secundários 0.723
  3. Aborrecida com a quantidade de tratamentos 0.771
Feelings about infertility (α = 0.880; n = 70 in 71)
  1. Preocupada com a possibilidade de não ter (mais) filhos 0.791
  2. Sentir-se diferente por não poder/ não conseguir ter (mais) filhos 0.824
  3. Sentir-se deprimida com a possibilidade de não ter (mais) filhos 0.793
  4. Sentir que a possibilidade de infertilidade provoca tensão na relação com o parceiro 0.573
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Portuguese version for all the dimensions.8
 As regards the comparison of the EHP-30 version in 
our study to the Brazilian Portuguese version, there are 
mainly differences regarding the language used. In fact, 
a translation that would ensure the semantic equivalence 
with the original instrument was sought in both versions 
and sought to at the same time ensure that the meaning 
and clinical relevance would be maintained both in the 
Portuguese or the Brazilian culture. Therefore, given 
the linguistic differences, the planning of questions was 
frequently different. For instance, the question ‘Felt your 
symptoms are taking away your life?’2 from the original 
version corresponded in the Brazilian Portuguese version 
to ‘Sentiu como se seus sintomas estivessem prejudicando 
a sua vida?’8 while in the Portuguese version analysed in 
our study corresponded to ‘Sentiu que os seus sintomas lhe 
estão a tirar vida?’ As regards the assessed psychometric 
properties, the different versions presented coefficients 
that show an excellent internal consistency and convergent 
validity, although different tests were used (SF-36v2 in 
our study vs. WHOQOL-Bref and the Beck’s Depression 
Inventory in the Brazilian Portuguese version).8
 In line with what was described in several validated 
versions of the EHP-30,16,17,21,24 the item-total correlation 
exceeded the minimum acceptable 0.4 coefficient in all the 
items in the core and modular questionnaires, corresponding 
to a good item-total consistency. 
 As regards the assessment of the convergent validity, a 
significant negative association between similar dimensions 
from the EHP-30 and the SF-36v2 questionnaires (the 
Portuguese version was previously validated as an 
instrument for the assessment of quality of life) was found. 
In fact, Pearson’s coefficient in our study was the same or 
even higher in all the dimensions, when compared to the 
original study.2 For instance, maximum correlation (0.73) 
was found on both studies between ‘pain’ in the EHP-30 and 
‘bodily pain’ in the SF-36v2. A maximum correlation between 
these dimensions was also found in the Chinese version of 
the EHP-30 and was significant in the seven hypothesized 
correlations.16 In addition, a maximum correlation was found 
between ‘emotional well-being’ in the EHP-30 and ‘role 
emotional’ in the SF-36 questionnaire.24
Table 5 - Correlation between the dimensions of core and modular questionnaires of the EHP-30 and the dimensions of the SF-36v2
EHP-30 SF-36v2 Pearson’s correlation a p
Pain Bodily pain -0.739 < 0.001
Pain Physical functioning -0.556 < 0.001
Control and powerlessness Social functioning -0.655 < 0.001
Control and powerlessness Role physical -0.559 < 0.001
Emotional well-being Role emotional -0.600 < 0.001
Emotional well-being Mental health -0.738 < 0.001
Emotional well-being General health -0.567 < 0.001
Social support Social functioning -0.628 < 0.001
Work Physical functioning -0.627 < 0.001
EHP-30: Endometriosis Health Profile-30; SF-36v2: MOS Short Form Health Survey – 36 Item - version 2; a: : Negative correlations as the EHP-30 and SF-36v2 scores follow different 
directions.
Table 6 - Descriptive statistics for the 5 dimensions of the core questionnaire and the 6 dimensions of the modular questionnaire of the 
EHP-30
Dimension n Mean ± SD Minimum Maximum Asymmetry Kurtosis
Core questionnaire
  Pain 147 37.11 ± 30.32 0   93.18  0.092 -1.503
  Control and powerlessness 150 40.94 ± 30.43 0   95.83  0.021 -1.373
  Emotional well-being 151 41.20 ± 27.43 0   95.83 -0.015 -1.134
  Social support 152 40.21 ± 29.17 0 100.00  0.004 -1.200
  Self-image 152 34.10 ± 27.57 0 100.00  0.303 -1.087
Questionário Modular
  Work 117 28.89 ± 30.09 0 100.00  0.558 -1.122
  Relationships with child/children 54 27.78 ± 29.00 0   87.50  0.529 -1.148
  Sexual relationships 112 46.12 ± 31.07 0 100.00 -0.109 -1.171
  Feelings about medical profession 121 12.76 ± 24.44 0 100.00  2.079  3.325
  Feelings about treatment 100 30.92 ± 28.46 0 100.00  0.418 -1.038
  Feeling about infertility   70 55.89 ± 28.92 0 100.00 -0.394 -0.617
mean ± SD: mean ± standard deviation.
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 Data completeness was high both in core and in 
modular questionnaire, explaining for its basic acceptability 
and comprehension. In fact, even the ‘sexual relationship’ 
dimension, which could involve more constraints, showed 
a 97.4% data completeness. The Brazilian Portuguese 
version of the EHP-30 already had shown to be an easily 
and quickly applied instrument, readily acceptance by 
patients.8
 In line with what was described in the core questionnaire 
from the Iranian version of the EHP-30, the highest median 
score was found in the ‘emotional well-being’ dimension and 
therefore with the most negative impact on quality of life.24 
In addition, like the North American and Australian versions, 
the ‘self-image’ dimension showed the lowest median 
score.21,22 In the modular questionnaire, in line with the 
original, Australian, Dutch, Iranian and Chinese versions, 
the ‘feelings about infertility’ dimension showed the highest 
median score and therefore the most negative impact on 
quality of life.2,16,17,22,24 According to our results and in line with 
literature, the decrease in emotional well-being and concerns 
regarding a possible infertility are the issues that have more 
impact on the quality of life in  endometriosis. The impact of 
endometriosis on quality of life has been largely shown and 
other aspects have been discussed.1,5,10,11,35,36 Nnoaham et 
al. described in their study involving 1,418 women from 10 
different countries that endometriosis impairs quality of life 
and labour productivity regardless of the patient’s origin or 
ethnicity.10 These results were confirmed by Fourquet et 
al. showing that endometriosis-related symptoms have an 
impact on absenteeism and reduce labour productivity, as 
well as reducing patient’s physical and mental well-being.35 
A more recent multi-centric study involving 931 women from 
10 countries, described a significant effect of endometriosis 
on patient’s physical, mental and social well-being, namely 
at work (51% of the patients) and in relationships (50%).36 It 
should be mentioned that the EHP-30 questionnaire allows 
for the assessment of different dimensions of quality of life, 
namely in ‘pain’, ‘control and powerlessness’, ‘emotional 
well-being’, ‘social support’ and ‘work’ dimensions.
 As regards the limitations to our study, the fact that 
the test-retest reliability and sensitivity to the change of 
questionnaire were not assessed should be mentioned. 
Despite acceptable intra-class correlation coefficients 
having been described for different versions,2,8,19,20 including 
the original, the sensitivity to the change of the Portuguese 
version of the questionnaire should be analysed in 
further studies as this is the only way the capability of the 
Portuguese version of the EHP-30 in measuring the effect 
of a certain therapy on the quality of life of Portuguese 
women with endometriosis could be determined.  
CONCLUSIONS
 Our study showed that the Portuguese version of 
the EHP-30 is an adequate, validated and well accepted 
instrument for assessing the quality of life in Portuguese 
women with endometriosis. This version will allow for the 
objective assessment of the quality of life in Portuguese 
women with endometriosis, as well as for the comparison 
with other studies in which this instrument is used. 
 Further studies are needed to assess test-retest 
reliability and sensitivity to the change of this Portuguese 
version of the EHP-30. If its adequacy is confirmed, this 
instrument may subsequently be used in assessment 
studies of therapeutic efficacy. 
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